SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000897204-13-000007
Filing Date
2013-02-14
Accepted
2013-02-14 15:03:25
Documents
2
Group Members
FRANCESCO MICHELIGENEXTRA S.P.A.LORENZO TALLARIGO

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sch13g.htm SC 13G 108957
2 EXH. 99 - JOINT FILING AGREEMENT exh991.htm EX-99 10669
  Complete submission text file 0000897204-13-000007.txt   121142
Mailing Address 18 Desbrosses Street New York NY 10013
Business Address 18 Desbrosses Street NEW YORK NY 10013 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Subject) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87033 | Film No.: 13612478
SIC: 2834 Pharmaceutical Preparations

Mailing Address VIA G. DE GRASSI, 11 MILAN L6 20123
Business Address VIA G. DE GRASSI, 11 MILAN L6 20123 390236515110
Genextra S.p.A. (Filed by) CIK: 0001559515 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L6 | Fiscal Year End: 1212
Type: SC 13G